Date:5/2/2011

including, but not limited to, those related to losses or system failures with respect to Abaxis' facilities or manufacturing operations, fluctuations in quarterly operating results, dependence on sole suppliers, the market acceptance of Abaxis' products and the continuing development of its products, required United States Food and Drug Administration clearance and other government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties, risks related to condition of the United States economy and other risks detailed under "Risk Factors" in Abaxis' Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010 and Abaxis' other periodic reports filed from time to time with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.  Contact:

Clint Severson

Lytham Partners, LLCChief Executive Officer

Joe Dorame, Robert Blum and Joe DiazAbaxis, Inc.

602-889-9700510-675-6500
'/>"/>

SOURCE Abaxis, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011
2. Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference
3. Abaxis, Inc. to Present at RBC Capital Markets Healthcare Conference
4. Abaxis Reports Financial Performance With Record Sales for the Third Quarter of Fiscal 2011
5. Abaxis to Report Third Quarter Fiscal 2011 Financial Results Thursday, January 27, 2011
6. Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus
7. Abaxis, Inc. to Present at Stephens Fall Investment Conference
8. Abaxis Reports Financial Performance with Record Sales for the Second Quarter of Fiscal 2011
9. Abaxis to Report Second Quarter Fiscal 2011 Financial Results Tuesday, October 26, 2010
10. Abaxis, Inc. to Present at Sidoti & Companys Ninth Annual West Coast Institutional Investor Forum
11. Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010